Physician

Abdul Mutalib Adjei, MD

According to 2025 Medicare claims, Abdul Adjei, MD (NPI: 1639351760) practices hematology/oncology, with the plurality of this provider's patient population coming from Sussex, DE. This provider's primary affiliated billing organization is BEEBE MEDICAL CENTER, INC. (NPI: 1821196486; TIN: 510067938) and primary practice location at 19958-1462. Adjei is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Adjei's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 390 traditional Medicare patients, billed 849 HCPCS/CPT codes, and received $70,523 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 333 prescription claims across 104 beneficiaries totaling $584,182 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2022 DME data shows 49 claims. Open Payments data shows 1 records totaling $32. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $43,982 and ending at $70,523. Concurrently, Part D prescription costs have risen steadily, from $226,519 to $584,182. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,797 to $2,013.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	245	648	$43,982
2016	257	691	$42,940
2017	287	737	$49,079
2018	263	644	$41,493
2019	302	726	$46,709
2020	333	667	$41,298
2021	341	718	$59,918
2022	314	598	$44,578
2023	348	501	$41,222
2024	390	849	$70,523

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	114	525	$226,519
2016	126	619	$368,135
2017	143	753	$983,452
2018	132	692	$1,685,821
2019	154	658	$1,673,529
2020	185	802	$2,254,281
2021	175	1,019	$2,478,637
2022	198	1,185	$4,084,710
2023	175	775	$2,531,596
2024	104	333	$584,182

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	187	$35,128
2016	N/R	135	$25,902
2017	N/R	71	$6,762
2018	11	145	$12,524
2019	N/R	250	$9,502
2020	N/R	69	$1,239
2021	N/R	108	$3,352
2022	N/R	49	$1,175
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	25	25	$142
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	89	197	$110
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	64	64	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	225	378	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	89	101	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	18	540	$230,629
Abiraterone Acetate	Abiraterone Acetate	20	600	$106,242
Eliquis	Apixaban	27	1,050	$20,698
Xarelto	Rivaroxaban	21	1,101	$19,689
Anastrozole	Anastrozole	27	2,310	$1,123

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$32	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Mutalib Adjei, MD?

Tedicare shows public-source Medicare data for Abdul Mutalib Adjei, MD (NPI 1639351760), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Mutalib Adjei, MD have ACO affiliation data?

Abdul Mutalib Adjei, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Abdul Mutalib Adjei, MD?

Abdul Mutalib Adjei, MD is linked to BEEBE MEDICAL CENTER, INC. (billing NPI 1821196486) in the available physician profile data.

Does Abdul Mutalib Adjei, MD have Open Payments data?

Abdul Mutalib Adjei, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.